Results · Apr-Jun 2026
Venus Remedies Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 36% to ₹179 crore from ₹132 crore in Apr-Jun 2025.
Operating profit grew 238% to ₹34.2 crore, an operating margin of 19.1% (up 11.5 points from a year ago).
Net profit grew 139% to ₹23 crore from ₹9.6 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −31%, net profit −52%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 178.9 | 131.9 | +36% |
| Operating profit (EBITDA) | 34.2 | 10.1 | +238% |
| Operating margin | 19.1% | 7.7% | +11.5 pts |
| Net profit | 23.0 | 9.6 | +139% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.